Concepedia

Holger Samer

HS

4

Publications

5.2K

Citations

4

H-Index

2003

Active since

Affiliations

University of Toronto(Current)

St. Michael's Hospital

Central Clinical Hospital

Victoria University of Wellington

Institut universitaire de cardiologie et de pneumologie de Québec

Holger Samer is an author at University of Toronto specializing in diabetes, medicine, and metabolic syndrome.

Top concepts

Publications per year

2003–2019

4

Publications

4

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus

Zsuzsa Kerényi, Holger Samer, Rachel James et al. · Diabetes Research and Clinical Practice · 2003 · 52 citations

, , +7

Rows per page

1–4 of 4